Series B is where the investor dynamic shifts meaningfully. At seed and Series A, you're often selling vision and early traction to investors who specialize in taking bets on potential. By Series B, the funds on this list are underwriting execution risk, not product-market fit risk—they assume you've already figured out what to build and for whom. That means your pitch needs to center on operational leverage: how efficiently you can deploy capital to grow, what your unit economics look like at scale, and whether your team can actually run a larger organization. These investors will dig into your data room harder than earlier-stage funds, and they'll want to see cohort analyses, retention curves, and a credible path to the numbers you're projecting.

​

One thing founders often underestimate: Series B leads tend to move slower and involve more internal stakeholders. Unlike seed investors who can often write a check off one partner's conviction, Series B funds typically require full partnership buy-in, which means multiple meetings, reference calls, and sometimes a formal investment committee process. Plan for 8-12 weeks from first meeting to term sheet, not 4. Also worth noting: many Series B leads will expect meaningful ownership (15-20%), so if your cap table is already crowded from earlier rounds, that conversation can get complicated. The funds here are also more likely to have strong opinions about board composition and governance—they're not just buying equity, they're buying a seat at the table for the next phase of your company's life.